Target Name: ZNF75A
NCBI ID: G7627
Review Report on ZNF75A Target / Biomarker Content of Review Report on ZNF75A Target / Biomarker
ZNF75A
Other Name(s): ZNF75A variant 2 | Zinc finger protein 75A | Zinc finger protein 75A (isoform 2) | zinc finger protein 75a | FLJ31529 | zinc finger protein 75D-like | Zinc finger protein 75a, transcript variant 2 | ZN75A_HUMAN

ZNF75A: A Potential Drug Target for Neural Stem Cells and Neurodegenerative Diseases

ZNF75A, also known as ZNF75A variant 2, is a gene that has been identified as a potential drug target or biomarker for various diseases. The ZNF75A gene is located on chromosome 16 and encodes for a protein known as ZNF75A. ZNF75A is a transcription factor that plays a role in regulating gene expression and is known for its role in the development and maintenance of tissues, including the brain.

Studies have shown that ZNF75A is involved in a number of important processes in the brain, including the development and maintenance of neural stem cells, the regulation of neurotransmitter release, and the response to changes in the environment. ZNF75A is also known to be involved in the development and progression of a number of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

One of the reasons why ZNF75A is considered a potential drug target is its role in the development of neurodegenerative diseases. By targeting ZNF75A with drugs, researchers hope to be able to slow down or even reverse the progression of these diseases. In addition, ZNF75A is also being studied as a potential biomarker for these diseases. By measuring the level of ZNF75A in brain tissue or blood samples, researchers can monitor the effectiveness of different treatments and determine whether a patient is responding to treatment.

Another reason why ZNF75A is considered a potential drug target is its role in the regulation of neural stem cells. Neural stem cells are a type of cell that have the ability to develop into any type of brain cell. By targeting ZNF75A with drugs, researchers hope to be able to stimulate neural stem cells to differentiate into specific types of cells and promote their growth and proliferation.

In addition to its role in the development and maintenance of neural stem cells, ZNF75A is also involved in the regulation of neurotransmitter release. Neurotransmitters are chemical messengers that are used by the brain to communicate with other cells and muscles. By targeting ZNF75A with drugs, researchers hope to be able to regulate neurotransmitter release and improve the function of the brain.

ZNF75A is also involved in the regulation of the immune response. The immune system is a critical part of the body's defense against infection and disease. By targeting ZNF75A with drugs, researchers hope to be able to regulate the immune response and improve the body's ability to fight off infections and diseases.

In conclusion, ZNF75A is a gene that has been identified as a potential drug target or biomarker for a number of diseases. Its role in the development and maintenance of neural stem cells, the regulation of neurotransmitter release, and the immune response makes it an attractive target for researchers. As more studies are conducted on ZNF75A, it is likely that we will learn more about its potential as a drug and its role in the development of various neurological diseases.

Protein Name: Zinc Finger Protein 75a

Functions: May be involved in transcriptional regulation

The "ZNF75A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF75A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF75CP | ZNF75D | ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766 | ZNF767P | ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772 | ZNF773 | ZNF774 | ZNF775 | ZNF776 | ZNF777 | ZNF778 | ZNF780A | ZNF780B | ZNF781 | ZNF782 | ZNF783 | ZNF784 | ZNF785 | ZNF786 | ZNF787 | ZNF788P | ZNF789 | ZNF79 | ZNF790 | ZNF790-AS1 | ZNF791 | ZNF792 | ZNF793 | ZNF799 | ZNF8 | ZNF8-ERVK3-1 | ZNF80 | ZNF800 | ZNF804A | ZNF804B | ZNF805 | ZNF807P | ZNF808 | ZNF81 | ZNF812P | ZNF813 | ZNF814 | ZNF815P | ZNF816 | ZNF816-ZNF321P | ZNF818P | ZNF821 | ZNF823 | ZNF826P | ZNF827 | ZNF829 | ZNF83 | ZNF830 | ZNF831 | ZNF833P | ZNF835 | ZNF836 | ZNF837 | ZNF839 | ZNF839P1 | ZNF84 | ZNF840P | ZNF841 | ZNF843 | ZNF844 | ZNF845 | ZNF846 | ZNF85 | ZNF850 | ZNF852 | ZNF853 | ZNF860 | ZNF862 | ZNF865 | ZNF875 | ZNF876P | ZNF878 | ZNF879 | ZNF880 | ZNF883 | ZNF887P | ZNF888 | ZNF890P | ZNF891 | ZNF90 | ZNF91 | ZNF92 | ZNF93 | ZNF962P | ZNF98 | ZNF99